Loading…

Integra LifeSciences announced plans to operationalize a new 100,000 square foot tissue manufacturing facility in Braintree, Massachusetts, in the first half of 2026, to manufacture PriMatrix and SurgiMend.
“The company plans on operationalizing this new state-of-the-art facility in the first half of 2026.”biospace.com
Summarized from public sources; check the original articles before acting on it.